SCHEMBL7136158

SCHEMBL7136158

CCCCCn1cc(C2CCNCC2)c2ccccc21

nearest known ligand 0.50

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
HRH2 P25021 1/20 0.49
HTR6 P50406 1/20 0.48
CNR2 P34972 9/20 0.47
CNR1 P21554 2/20 0.47
CDC25A P30304 1/20 0.46
ICMT O60725 1/20 0.45
HTR2A P28223 1/20 0.45
HTR2C P28335 1/20 0.45
HTR2B P41595 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4055511 0.96 HRH2 (0.53) HRH2HTR6CNR2CNR1HTR2A
SCHEMBL8316249 0.85 HTR6 (0.53) HTR6HTR2C
SCHEMBL4058347 0.82 HRH2 (0.58) HRH2HTR6HTR2AHTR2CHTR2B
SCHEMBL4056205 0.82 HTR6 (0.48) HRH2HTR6CNR2CNR1HTR2A
SCHEMBL27478068 0.80 HRH2 (0.55) HRH2CNR2CNR1CDC25AICMT
SCHEMBL5749097 0.79 CNR2 (0.41) HRH2HTR6CNR2CNR1HTR2A
SCHEMBL6781286 0.79 HTR6 (0.52) HRH2HTR6CNR2CNR1HTR2C
SCHEMBL5937271 0.78 HTR6 (0.57) HTR6HTR2C
SCHEMBL5342259 0.78 CNR2 (0.53) HTR6CNR2CNR1
SCHEMBL5339248 0.78 HRH2 (0.56) HRH2HTR6CNR2CNR1HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0575430-B1 PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF ADDICTION TO DRUGS AND SUBSTANCES OF ABUSE LUNDBECK & CO AS H (DK) 1998-08-05 EP claimed
EP-0575429-B1 TREATMENT OF COGNITIVE DISORDERS LUNDBECK & CO AS H (DK) 1995-12-06 EP claimed
US-5462948-A Treatment of addiction to drugs and substances of abuse H. LUNDBECK A/S (DK) 1995-10-31 US claimed
US-5439922-A Administering dopamine antagonists having reduced side effects H. LUNDBECK A/S (DK) 1995-08-08 US claimed
EP-0533824-B1 PIPERIDYL-SUBSTITUTED INDOLES LUNDBECK & CO AS H (DK) 1994-11-09 EP claimed
EP-0575429-A1 TREATMENT OF COGNITIVE DISORDERS. LUNDBECK & CO AS H (DK) 1993-12-29 EP claimed
EP-0575430-A1 PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF ADDICTION TO DRUGS AND SUBSTANCES OF ABUSE H. LUNDBECK A/S (DK) 1993-12-29 EP claimed
EP-0533824-A1 PIPERIDYL-SUBSTITUTED INDOLES. LUNDBECK & CO AS H (DK) 1993-03-31 EP claimed
WO-1992015302-A1 TREATMENT OF ADDICTION TO DRUGS AND SUBSTANCES OF ABUSE H. LUNDBECK A/S (DK) 1992-09-17 WO claimed
WO-1992015301-A1 TREATMENT OF HYPERTENSION AND PERIPHERAL VASCULAR DISEASES H. LUNDBECK A/S (DK) 1992-09-17 WO claimed
WO-1992015303-A1 TREATMENT OF COGNITIVE DISORDERS H. LUNDBECK A/S (DK) 1992-09-17 WO claimed
WO-1992000070-A1 PIPERIDYL-SUBSTITUTED INDOLES H. LUNDBECK A/S (DK) 1992-01-09 WO claimed
EP-1068198-B1 5-HETEROARYL SUBSTITUTED INDOLES LUNDBECK & CO AS H (DK) 2003-05-28 EP disclosed
EP-0575430-B1 PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF ADDICTION TO DRUGS AND SUBSTANCES OF ABUSE LUNDBECK & CO AS H (DK) 1998-08-05 EP disclosed
EP-0575430-B1 PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF ADDICTION TO DRUGS AND SUBSTANCES OF ABUSE LUNDBECK & CO AS H (DK) 1998-08-05 EP disclosed
EP-0575429-B1 TREATMENT OF COGNITIVE DISORDERS LUNDBECK & CO AS H (DK) 1995-12-06 EP disclosed
WO-1992015302-A1 TREATMENT OF ADDICTION TO DRUGS AND SUBSTANCES OF ABUSE H. LUNDBECK A/S (DK) 1992-09-17 WO disclosed
WO-1992015302-A1 TREATMENT OF ADDICTION TO DRUGS AND SUBSTANCES OF ABUSE H. LUNDBECK A/S (DK) 1992-09-17 WO disclosed
WO-1992000070-A1 PIPERIDYL-SUBSTITUTED INDOLES H. LUNDBECK A/S (DK) 1992-01-09 WO disclosed
WO-1992000070-A1 PIPERIDYL-SUBSTITUTED INDOLES H. LUNDBECK A/S (DK) 1992-01-09 WO disclosed